Neos Therapeutics, Inc. (NASDAQ: NEOS)

Rowley Law PLLC is investigating potential securities law violations by Neos Therapeutics, Inc. (NASDAQ: NEOS) and its board of directors concerning the proposed acquisition of the company by Aytu BioScience, Inc. (NASDAQ: AYTU). Stockholders will receive 0.1088 shares of Aytu BioScience common stock for each share of Neos Therapeutics stock that they hold. The transaction is valued at approximately $44.9 million and is expected to close by the second quarter of 2021.

If you are a stockholder of Neos Therapeutics, Inc. and are interested in obtaining additional information regarding this investigation, please fill in the contact form on this page. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Request Information

The submission of this form does not create an attorney-client relationship.

2020-12-10T21:10:36+00:00